AzTrials
AzTrials

Diplegic Cerebral Palsy With SpasticityNCT07287215

Motor Imagery and Functional Performance in Diplegic Cerebral Palsy

An observational study of Diplegic Cerebral Palsy With Spasticity and Motor İmagery Ability, run by Inonu University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The main purpose of this study was to examine the relationship between motor imagery capacity and functional mobility, walking and balance in children with diplegic type cerebral palsy. Read more about this study

Who is it for?
Ages 5 to 18 yearsHealthy volunteers can take part
What is being tested?
Motor Imagery Ability Assessment, Mental Stopwatch Paradigm and Functional Mobility
How many people
99 participants
Where
1 siteTurkey (Türkiye)
Study dates
24 Nov 2025to 26 Feb 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: diplegic cerebral palsy

Who may be able to join

  • Diagnosed with diplegic CP by a neurologist or pediatric neurologist
  • Being between 5 and 18 years of age
  • Being between levels I and III on the GMFCS
  • Having the cognitive ability to follow the assessment instructions
  • Informed consent form has been obtained from the child's family
  • The child has agreed to participate voluntarily in the study

Who cannot join

  • Having severe impairments in basic sensory systems such as vision or hearing
  • Having additional diagnoses such as epilepsy or autism spectrum disorder
  • Demonstrating cognitive or behavioral problems that prevent them from following instructions during the assessment
  • Having informed consent from the child's family or the child

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

dilan demirtas karaoba, asst. prof, asst. prof contact

+905541127796

dilandemirtas92@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Bingöl

    Bingoel

    Büşra Candiri, asst. prof, 0 507 378 07 17, busracandiri@gmail.com

    Hasan BİNGÖL, asst. prof, +90 507 232 81 00

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Relationship Between Motor Imagery Ability and Functional Mobility, Walking, and Balance in Children With Diplegic Cerebral Palsy

The main purpose of this study was to examine the relationship between motor imagery capacity and functional mobility, walking and balance in children with diplegic type cerebral palsy.

Read the detailed description

This study will be conducted using a cross-sectional and correlational screening model to examine the relationship between motor imagery ability and functional mobility, walking, and balance in children with diplegic cerebral palsy. Data collection will be conducted through one-on-one assessments after obtaining written consent from volunteer participants and their families. The data collection tools used in the study are listed below: Demographic Information Form, Motor Imagery Ability Assessment, Mental Stopwatch Paradigm, Functional Mobility, and Gait Assessment.

Being tested
Motor Imagery Ability Assessment, Mental Stopwatch Paradigm, Functional Mobility, Gait assessment:

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motor Imagery Ability AssessmentOther

    Laterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute

  • Mental Stopwatch ParadigmOther

    A mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.

  • Functional MobilityOther

    Functional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS) and the Timed Up and Go test.

  • Gait assessment:Other

    Gait assessment: The Gillette FDA is a self- or observer-based assessment tool.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mental Stopwatch Paradigm

    A mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.

    Measured: 24-48 hours

  2. Laterality Task (Choice Task):

    Laterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute

    Measured: 24-48 hours

  3. Functional Mobility using the Functional Mobility Scale (FMS)

    Functional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS)

    Measured: 24-48 hours

  4. Functional Mobility using the Timed Up and Go test

    Functional Mobility: Functional Mobility will be assessed using the Timed Up and Go test.

    Measured: 24-48 hours

  5. The Gillette Functional Assessment Questionnaire

    Gait assessment: The Gillette Functional Assessment Questionnaire is a self- or observer-based assessment tool, minimum score 22 maximum score 88

    Measured: 24-48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2025
  2. Study start24 Nov 2025
  3. Primary completion23 Feb 2026 (estimated)
  4. Study completion26 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
99 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07287215
Sponsor's protocol ID
2025/0725
Status last verified
Dec 2025
First submitted
2 Dec 2025
Last updated
17 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Diplegic Cerebral Palsy With Spasticity and Motor İmagery Ability, run by Inonu University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact dilan demirtas karaoba, asst. prof, asst. prof (+905541127796, dilandemirtas92@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mental Stopwatch Paradigm (time frame: 24-48 hours). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in